Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade GliomaJ. Clin. Oncol 2020 Jul 24;[EPub Ahead of Print], EH Bell, P Zhang, EG Shaw, JC Buckner, GR Barger, DE Bullard, MP Mehta, MR Gilbert, PD Brown, KJ Stelzer, JP McElroy, JL Fleming, CD Timmers, AP Becker, AL Salavaggione, Z Liu, K Aldape, DG Brachman, SZ Gertler, AD Murtha, CJ Schultz, D Johnson, NN Laack, GK Hunter, IR Crocker, M Won, A Chakravarti
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.